Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Polifka, Iris; Agaimy, Abbas; Herrmann, Edwin et al.
High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinomaHUMAN PATHOLOGY. Bd. 83. 2019 S. 212-223
Kreft, Andreas; Neumann, Helmut; von Bach, Danjell Sartorius et al.
Histologic diagnosis and grading of esophageal acute graft-versus-host diseaseVIRCHOWS ARCHIV. Bd. 474. H. 3. 2019 S. 325-332
van der Sluis, Pieter Christiaan; Grimminger, Peter Philipp; van Hillegersberg, Richard et al.
Hybrid minimally invasive esophagectomy for esophageal cancer: less is moreJOURNAL OF THORACIC DISEASE. Bd. 11. 2019 S. S1935-S1937
Rule, Simon; Dreyling, Martin; Goy, Andre et al.
Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysisHAEMATOLOGICA. Bd. 104. H. 5. 2019 S. E211-E214
Vewinger, Nadine; Huprich, Sabrina; Seidmann, Larissa et al.
IGF1R Is a Potential New Therapeutic Target for HGNET-BCOR Brain Tumor PatientsINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Bd. 20. H. 12. 2019
Grivas, Petros; Monk, Bradley J.; Petrylak, Daniel et al.
Immune Checkpoint Inhibitors as Switch or Continuation Maintenance Therapy in Solid Tumors: Rationale and Current StateTARGETED ONCOLOGY. Bd. 14. H. 5. 2019 S. 505-525
Almstedt, K; Schmidt, M
Immunonkologie beim Mammakarzinom – von der Diagnose bis zur TherapieOnkologie heute. Bd. 12. 2019 S. 32-36
Heimes, AS; Almstedt, K; Schmidt, M
Immunonkologie beim triple-negativen MammakarzinomFrauenheilkunde up2date. Bd. 13. 2019 S. 339-349
Banys-Paluchowskil, Malgorzata; Krawczyk, Natalia; Friebe, Verena et al.
Immunotherapy for breast cancerGYNAKOLOGE. Bd. 52. H. 5. 2019 S. 343-353
Tannapfel, Andrea; Reinacher-Schick, Anke; Hacker, Ulrich et al.
Immunotherapy: New Options in Gastrointestinal Cancers?VISCERAL MEDICINE. Bd. 35. H. 1. 2019 S. 47-51